These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10864400)

  • 1. In vitro studies with fexofenadine, a new nonsedating histamine H1 receptor antagonist, on isolated human basophils.
    Amon U; Amon S; Gibbs BF
    Inflamm Res; 2000 Apr; 49 Suppl 1():S13-4. PubMed ID: 10864400
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of H1 and H2 receptor blockers on immunological and nonspecific histamine release from isolated target cells.
    Hofman J; Siergiejko Z; Kuczewska B; Chyrek-Borowska S
    Arch Immunol Ther Exp (Warsz); 1984; 32(5):599-604. PubMed ID: 6085468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fexofenadine on the early response to nasal allergen challenge.
    Allocco FT; Votypka V; deTineo M; Naclerio RM; Baroody FM
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):578-84. PubMed ID: 12487223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct effects of second-generation H1-receptor antagonists on the activation of human basophils.
    Ramachers U; Amon U; Wolff HH
    Agents Actions; 1994 Jun; 41 Spec No():C45-6. PubMed ID: 7526656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of terfenadine on mediator release from human blood basophils and eosinophils.
    Nabe M; Agrawal DK; Sarmiento EU; Townley RG
    Clin Exp Allergy; 1989 Sep; 19(5):515-20. PubMed ID: 2477125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivity of human basophils to anti-IgE and protein A in atopic dermatitis.
    Sainte-Laudy J; Henocq E
    Agents Actions; 1990 Apr; 30(1-2):250-3. PubMed ID: 1695448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of terfenadine on the immediate and late-phase reactions mediated by immunoglobulin E.
    de Weck AL; Derer T; Bischoff SC; Takafuji S
    Int Arch Allergy Immunol; 1993; 101(3):326-32. PubMed ID: 7686799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mite-antigen induced immediate reactions in atopic dermatitis are inhibited by daily administration of fexofenadine.
    Urabe K; Nakahara T; Moroi Y; Morita K; Furue M
    J Dermatol; 2003 Nov; 30(11):847-8. PubMed ID: 14684947
    [No Abstract]   [Full Text] [Related]  

  • 9. Twenty-four hours of activity of cetirizine and fexofenadine in the skin.
    Purohit A; Duvernelle C; Melac M; Pauli G; Frossard N
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):387-92. PubMed ID: 11345280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of H1-antihistamines on histamine release from dispersed canine cutaneous mast cells.
    García G; DeMora F; Ferrer L; Puigdemont A
    Am J Vet Res; 1997 Mar; 58(3):293-7. PubMed ID: 9055977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological modulation of human mast cells and basophils.
    Marone G; Genovese A; Granata F; Forte V; Detoraki A; de Paulis A; Triggiani M
    Clin Exp Allergy; 2002 Dec; 32(12):1682-9. PubMed ID: 12653156
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of fexofenadine--selective antagonist of histamine receptor (H1) on histamine-induced bronchoconstriction].
    Grzelewska-Rzymowska I; Kroczyńska-Bednarek J; Pietrzkowicz M
    Pol Merkur Lekarski; 2003 Jan; 14(79):43-6. PubMed ID: 12712828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral H1-blockade effect of fexofenadine.
    Simons FE; Simons KJ
    Ann Allergy Asthma Immunol; 1997 Dec; 79(6):530-2. PubMed ID: 9433369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative potency of fexofenadine HCl 180 mg, loratadine 10 mg, and placebo using a skin test model of wheal-and-flare suppression.
    Kaliner MA; White MV; Economides A; Crisalida T; Hale M; Liao Y; Christian CD; Georges GC; Woodworth TH; Meeves SG
    Ann Allergy Asthma Immunol; 2003 Jun; 90(6):629-34. PubMed ID: 12839321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
    Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K
    J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous IgE-mediated inflammatory lesion size is inhibited by an H1 antagonist (terfenadine) while mediator release is unaffected in vivo and in vitro.
    Massey WA; Charlesworth EN; Freidhoff L; Cooper P; Kagey-Sobotka A; Lichtenstein LM
    Clin Exp Allergy; 1993 May; 23(5):399-405. PubMed ID: 7687510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of fexofenadine on pruritus in a mouse model (HR-ADf) of atopic dermatitis.
    Akamatsu H; Makiura M; Yamamoto N; Yagami A; Shimizu Y; Matsunaga K
    J Int Med Res; 2006; 34(5):495-504. PubMed ID: 17133778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fexofenadine: a antihistaminic. Review of its practical characteristics].
    Caballero E; Ocaña I; Azanza JR; Sádaba B
    Rev Med Univ Navarra; 1999; 43(2):93-7. PubMed ID: 11256010
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-inflammatory activity of H1-receptor antagonists: review of recent experimental research.
    Gelfand EW; Appajosyula S; Meeves S
    Curr Med Res Opin; 2004 Jan; 20(1):73-81. PubMed ID: 14741075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of some additives for the improvement of terfenadine performance.
    Ghorab M; Nada AH; Ghorab MM; Hammady TH
    Pharmazie; 2002 Nov; 57(11):772-3. PubMed ID: 12611283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.